Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

INOTERSEN SODIUM

FDA · NDA · 2024-11-22

AgencyFDA
Submission typeNDA
Action date2024-11-22
BrandTEGSEDI
SponsorAKCEA THERAPS
RouteSUBCUTANEOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:49.109Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:INOTERSEN SODIUM:2024-11-22

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

INOTERSEN SODIUM — approval | AEaH